The use of structural alerts to avoid the toxicity of pharmaceuticals-Reference-Cited by-同舟云学术

The use of structural alerts to avoid the toxicity of pharmaceuticals

Published:2018 Issue: Volume:5 Page:943-953
ISSN:2214-7500
Container-title:Toxicology Reports
language:en
Short-container-title:Toxicology Reports

Author:

Limban Carmen^ORCID,Nuţă Diana C.,Chiriţă Cornel^ORCID,Negreș Simona,Arsene Andreea L.^ORCID,Goumenou Marina,Karakitsios Spyros P.,Tsatsakis Aristidis M.,Sarigiannis Dimosthenis A.

Publisher

Elsevier BV

Subject

Health, Toxicology and Mutagenesis,Toxicology

Reference42 articles.

1. Systematic approach to organizing structural alerts for reactive metabolite formation from potential drugs;Claesson;Chem. Res. Toxicol.,2018

2. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States;Stepan;Chem. Res. Toxicol.,2011

3. Immune-mediated adverse drug reactions;Uetrecht;Chem. Res. Toxicol.,2009

4. Peroxidases: a role in the metabolism and side effects of drugs;Tafazoli;Drug Discov. Today,2005

5. EMA/CHMP/ICH/126642/2008 - European Medicines Agency - ICH Guideline S2 (R1) on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use;EMEA,2008

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide-Based Strategies: Combating Alzheimer’s Amyloid β Aggregation through Ergonomic Design and Fibril Disruption;Biochemistry;2024-09-10

2. An adaptive and interpretable modeling architecture assisted rapid and reliable consensus prediction for hazardous properties of chemicals;Journal of Cleaner Production;2024-09

3. Use of Structural Alerts for Reactive Metabolites in the Application SpotRM;Chemical Research in Toxicology;2024-08-01

4. Bioactivation and reactivity research advances – 2023 year in review;Drug Metabolism Reviews;2024-07-17

5. Computational Docking as a Tool in Guiding the Drug Design of Rutaecarpine Derivatives as Potential SARS-CoV-2 Inhibitors;Molecules;2024-06-03